Our New USDA FBS is Tet Free
Compare and Save!In researching Neuromics ' Competitors pricing on Tetracycline Free FBS, I noticed pricing ranging from $650-1,000+. Check us out. Only $299/500 ml. bottle.FBS - Fetal Bovine Serum USDA OriginFBS002500 mL$299.00Here ' s our COA.To learn more simply emailrose@neuromics.com. (Source: Neuromics)
Source: Neuromics - February 5, 2020 Category: Neuroscience Tags: FBS Fetal Bovine Serum Tet free Tetracycline free Source Type: news
How Is Hidradenitis Suppurativa Treated?
Discussion
Hidradenitis suppurativa (HS) is a recurrent, chronic inflammatory disease of the hair follicles particularly in the apocrine gland-bearing areas of the axilla, inguinal, perianal, mammary and inframammary areas. Onset is usually after puberty, in the early 20s. It is more common in females than males. Prevalence is estimated to be 0.05- 4.1%. It can be associated with premature adrenarche, metabolic syndrome and obesity.
The lesions are often pruritic, painful, and with malodorous purulent drainage. It often begins with comedomes and tender nodules, and can easily progress to painful abscesses with purulent f...
Source: PediatricEducation.org - November 25, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Phillips Company Issues Voluntary Worldwide Recall of All Topical Products Due to Concerns of Manufacturing Practices
Phillips Company is voluntarily recalling all lots of Tetrastem, Diabecline, Tetracycline-ABC, VenomX, Acneen, StaphWash, StringMed, NoPain and LidoMed distributed by Phillips Company, with business offices located in Sun City, Arizona, to the retail level. The products are being recalled after an FDA inspection found significant manufacturing practices that calls into question the safety, identity, strength, quality and purity of unexpired drug products made at the firm during the past three years. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 5, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer
Drug-resistance dissemination by horizontal gene transfer remains poorly understood at the cellular scale. Using live-cell microscopy, we reveal the dynamics of resistance acquisition by transfer of the Escherichia coli fertility factor–conjugation plasmid encoding the tetracycline-efflux pump TetA. The entry of the single-stranded DNA plasmid into the recipient cell is rapidly followed by complementary-strand synthesis, plasmid-gene expression, and production of TetA. In the presence of translation-inhibiting antibiotics, resistance acquisition depends on the AcrAB-TolC multidrug efflux pump, because it reduces tetr...
Source: ScienceNOW - May 22, 2019 Category: Science Authors: Nolivos, S., Cayron, J., Dedieu, A., Page, A., Delolme, F., Lesterlin, C. Tags: Cell Biology, Microbiology reports Source Type: news
Project aims to revive natural product discovery
(Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign) The mid-20th century was the golden age of natural product discovery. Scientists discovered groundbreaking drugs, like penicillin and tetracycline, from sources in nature. But as the search for natural products continued, pharmaceutical companies kept finding the same products over and over again. The era of genomics brought success in discovering new natural products, but only on a very small scale. Now, a new project aims to discover new natural products on a large scale by using synthetic biology and automation. (Source: EurekAlert...
Source: EurekAlert! - Medicine and Health - April 23, 2019 Category: International Medicine & Public Health Source Type: news
Pain Creams and Gels; Reducing Delirium: It's PodMed Double T! (with audio)
(MedPage Today) -- This week ' s topics also include a new tetracycline class antibiotic; and are you ever too old for statins? (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 9, 2019 Category: Cardiology Source Type: news
New Antibiotic Treats Pneumonia, Skin Infections
Omadacycline, a revamped, "modernized" version of tetracycline, is aimed at people who get sick out in the real world -- not the seriously ill hospital patient whose infection may resist many other antibiotics. (Source: WebMD Health)
Source: WebMD Health - February 6, 2019 Category: Consumer Health News Source Type: news
Achromycin V (tetracycline) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 5, 2019 Category: Drugs & Pharmacology Source Type: news
Antibiotic explorers
(Harvard University) In clinical trials, tetracycline antibiotics have proven effective in treating some pathological inflammation and cancer. And yet, despite promising results, exactly how the treatment works remained elusive. Now, after much painstaking exploration, we have an answer as well as a new technique to find similar answers numerous other drugs. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2018 Category: Cancer & Oncology Source Type: news
FDA Clears Omadacycline (Nuzyra) for ABSSSI and CABP FDA Clears Omadacycline (Nuzyra) for ABSSSI and CABP
Omadacycline is a modernized tetracycline with broad-spectrum activity that is designed to overcome tetracycline resistance.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 3, 2018 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news
FDA Clears Omadacycline (Nuzyra) for Two Infections FDA Clears Omadacycline (Nuzyra) for Two Infections
Omadacycline is a modernized tetracycline with broad-spectrum activity that is designed to overcome tetracycline resistance.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 3, 2018 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news
FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
Barcelona - 2nd October 2018 -- Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived oral antibiotic for the treatment of inflammatory... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 2, 2018 Category: Drugs & Pharmacology Source Type: news
Trachoma elimination: Iranians triumph against the world ’s leading infectious cause of blindness
26 September 2018 Tehran Cairo Geneva The World Health Organization (WHO) has validated the elimination of trachoma as a public health problem in the Islamic Republic of Iran. By achieving this milestone, the country becomes the third in WHO’s Eastern Mediterranean Region, after Oman in 2012 and Morocco in 2016, to overcome this centuries-old disease.
“WHO is pleased to have supported the Islamic Republic of Iran through the validation process,” said Dr Ahmed Al-Mandhari, WHO Regional Director for the Eastern Mediterranean. “But this achievement was made possible by the Government and people of Islamic Republic of...
Source: WHO EMRO News - September 26, 2018 Category: Middle East Health Source Type: news
Actisite (Tetracycline Periodontal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 28, 2018 Category: Drugs & Pharmacology Source Type: news
FDA Advisors Like Novel Tetracycline Analogue
(MedPage Today) -- Recommend approval for omadacycline in pneumonia, skin infections (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 8, 2018 Category: American Health Source Type: news
